RETRACTED: Beneficial effect of etidronate therapy in chronically hospitalized, disabled patients with stroke.

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief due to data fabrication, systematic authorship misconduct, text duplication, concerns about data integrity, and scientific misconduct. In addition, several publications reporting non-randomized research by members of this group of investigators have been retracted.

• Authors: Yoshihiro Sato, Jun Iwamoto, Yoshiaki Honda
• Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association (J Stroke Cerebrovasc Dis) Vol. 19 Issue 3 Pg. 198-203 (05 2010) ISSN: 1532-8511 [Electronic] United States
• PMID: 20434046 (Publication Type: Journal Article, Randomized Controlled Trial, Retracted Publication)
• Copyright: Copyright (c) 2010 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Chemical References

• Bone Density Conservation Agents
• Parathyroid Hormone
• Vitamin D
• Etidronic Acid
• Calcium

Topics

• Aged
• Body Mass Index
• Bone Density (drug effects)
• Bone Density Conservation Agents (adverse effects, therapeutic use)
• Calcium (metabolism)
• Chronic Disease
• Disabled Persons
• Disease Progression
• Double-Blind Method
• Etidronic Acid (adverse effects, therapeutic use)
• Female
• Hip Fractures (epidemiology, prevention & control)
• Hospitalization
• Humans
• Male
• Osteoporosis (complications, prevention & control)
• Parathyroid Hormone (blood)
• Stroke (complications)
• Sunlight
• Vitamin D (metabolism)